Peptide5

• Description :

  Peptide5, a connexin 43 mimetic peptide, reduce animals swelling, astrogliosis, and neuronal cell death after spinal cord injury[1]

• UNSPSC :

  12352209

• Target :

  Connexin; Gap Junction Protein

• Type :

  Peptides

• Related Pathways :

  Cytoskeleton

• Field of Research :

  Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/peptide5.html

• Purity :

  98.39

• Solubility :

  DMSO : 100 mg/mL (ultrasonic)

• Smiles :

  C[C@@H](O)[C@@H](C(O)=O)NC([C@H](CCCCN)NC([C@H](CCC(O)=O)NC([C@H]([C@H](O)C)NC([C@H]1N(C([C@H](CCCNC(N)=N)NC([C@H](CO)NC([C@H](CC(C)C)NC([C@H](CC2=CC=CC=C2)NC([C@H](CS)NC([C@H](CC(O)=O)NC([C@H](C(C)C)N)=O)=O)=O)=O)=O)=O)=O)CCC1)=O)=O)=O)=O

• Molecular Formula :

  C60H98N16O20S

• Molecular Weight :

  1395.58

• References & Citations :

  [1]Simon J O'Carroll, et al. Connexin 43 mimetic peptides reduce swelling, astrogliosis, and neuronal cell death after spinal cord injury. Cell Commun Adhes. 2008 May;15 (1) :27-42.|[2]Yilin Mao, et al. Characterisation of Peptide5 systemic administration for treating traumatic spinal cord injured rats. Exp Brain Res. 2017 Oct;235 (10) :3033-3048.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

• Scientific Category :

  Peptides

• Clinical Information :

  No Development Reported

• CAS Number :

  [916977-43-0]